Golf Muscle Master explains that tirzepatide acts on GIP and GLP-1 receptors, tied to appetite, stomach emptying and blood sugar, versus triple agonists.
Recap by typeshit. Post by @golfmusclemaster on Instagram.
A short post credits scientists with finding axolotl peptides that kill breast cancer cells. It names no study or team, so treat it as an early claim.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
Amgen shares are up about 24% this year on interest in its obesity candidate MariTide. One bearish take flags manufacturing scale and a crowded GLP-1 market.
In a new suit, Frank Campbell Jr. claims he developed gastroparesis after starting the drugs, leaving him with debilitating nausea, vomiting and abdominal pain.
Loading…